Mitochondria-targeted antioxidant mitoq reduces gentamicin-induced ototoxicity

Otology and Neurotology

Volumn 35, Issue 3, 2014, Pages 533-539

  Ojano Dirain, Carolyn P ^a   Antonelli, Patrick J ^a   Le Prell, Colleen G ^b  

^a Departments of Otolaryngology Head and Neck Surgery   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aminoglycosides; Antioxidants; Gentamicin; MitoQ; Ototoxicity

Indexed keywords

ANTIOXIDANT; DRUG DERIVATIVE; GENTAMICIN; MITOQUINONE; ORGANOPHOSPHORUS COMPOUND; SUPEROXIDE DISMUTASE; UBIQUINONE;

ANIMAL; APOPTOSIS; ARTICLE; CHEMICALLY INDUCED DISORDER; COCHLEA; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HEARING IMPAIRMENT; INNER EAR DISEASE; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; COCHLEA; COCHLEAR DISEASES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GENTAMICINS; GUINEA PIGS; HEARING LOSS; MITOCHONDRIA; ORGANOPHOSPHORUS COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; UBIQUINONE;

EID: 84894622384     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000192     Document Type: Article

References (44)

1. Mascaretti O. Bacteria Versus Antibacterial Agents: An Integrated Approach. Washington, DC: ASM Press, 2003:229-333.
2. Shea PF, Richey PA, Wan JY, Stevens SR. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Ménière's disease. Laryngoscope 2012;122:204-11.
3. Huon L-K, Fang T-Y, Wang P-C. Outcomes of intratympanic gentamicin injection to treat Ménière's disease. Otol Neurotol 2012;33: 706-14.
4. Chambers HF. The aminoglycosides. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill, 2001:1219-38.
5. Dulon D, Hiel H, Aurousseau C, et al. Pharmacokinetics of gentamicin in the sensory hair cells of the organ of Corti: rapid uptake and long term persistence. C R Acad Sci III 1993;316:682-7.
6. Rybak LP, Ramkumar V. Ototoxicity. Kidney Int 2007;71:931-5.
7. Park SK, Choi D, Russell P, et al. Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope 2004;114:768-71.
8. Himeno C, Komeda M, Izumikawa M, et al. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002;167:61-70.
9. Sha SH, Schacht J. Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear Res 2000;142:34-40.
10. Campbell KCM, Meech RP, Klemens JJ, et al. Prevention of noiseand drug-induced hearing loss with D-methionine. Hear Res 2007;226:92-103.
11. Fetoni AR, Sergi B, Ferraresi A, et al. alpha-Tocopherol protective effects on gentamicin ototoxicity: an experimental study. Int J Audiol 2004;43:166-71.
12. Sha SH, Qiu JH, Schacht J. Aspirin to prevent gentamicin-induced hearing loss. N Engl J Med 2006;354:1856-7.
13. Patten DA, Germain M, Kelly MA, Slack RS. Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis 2010;20:357-67.
14. Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Ann Rev Pharmacol Toxicol 2007;47:629-56.
15. Murphy MP, Smith RA. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Revs 2000;41:235-50.
16. Smith RAJ, Porteous CM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999;263: 709-16.
17. Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant Mito-Q. Ann N Y Acad Sci 2010; 1201:96-103.
18. Matthews RT, Yang L, Browne S, et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998;95:8892-7.
19. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995;1271:195-204.
20. Rodriguez-Cuenca S, Cocheme HM, Logan A, et al. Consequences of long-term oral administration of the mitochondria-targeted antioxidantMitoQtowild- typemice. Free Radic BiolMed 2010;48:161-72.
21. Ojano-Dirain CP, Antonelli PJ. Prevention of gentamicin-induced apoptosis with the mitochondria-targeted antioxidant mitoquinone. Laryngoscope 2012;122:2543-8.
22. LePrell CG, Hughes LF, Miller JM. Free radical scavengers, vitamins A, C, and E, plus magnesium reduces noise trauma. Free Radic Biol Med 2007;42:1454-63.
23. Kalinec GM, Fernandez-Zapico ME, Urrutla R, Esteban-Cruciani N, Chen S, Kalinec F. Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss. Proc Natl Acad Sci USA 2005;102:16019-24.
24. Ojano-Dirain CP, Glushakova LG, Zhong L, et al. AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1: potential utility of tyrosine-mutant vectors in developing an animal model of PDH deficiency. Mol Genet Metab 2010;101:183-91.
25. Hiona A, Sanz A, Kujoth GC, et al. Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS One 2010;5:e11468.
26. Le Prell CG, Bao J. Prevention of noise-induced hearing loss: potential therapeutic agents. In: Le Prell CG, Henderson D, Fay RR, Popper AN, eds. Noise-Induced Hearing Loss: Scientific Advances, Springer Handbook of Auditory Research. New York, NY: Springer Science + Business Media, LLC, 2011:285-338.
27. Campbell KCM, Le Prell CG. Potential therapeutic agents. Semin Hearing 2012;33:97-113.
28. Sullivan MJ, Rarey KE, et al. Comparative ototoxicity of gentamicin in the guinea pig and two strains of rats. Hear Res 1987;31:161-7.
29. Adlam VJ, Harrison JC, Porteous CM, et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005;19:1088-95.
30. Graham D, Huyn NN, Hamilton CA, et al. The mitochondria targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009;54:322-8.
31. Lowes DA, Thottakam BMV, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 2008;45:1559-65.
32. Neuzil J, Widen C, Gellert N, et al. Mitochondria transmit apoptosis signaling in cardiomyocyte-like cells and isolated hearts exposed to experimental ischemia-reperfusion injury. Redox Rep 2007;12:148-62.
33. Supinski GS, Murphy MP, Callahan LA. MitoQ administration prevents endotoxin induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol 2009;297:R1095-102.
34. Snow BJ, Rolfe FL, Lockhart MM, et al. A double-blind, placebocontrolled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Dis 2010;25:1670-4.
35. Gane EJ, Orr DW, Weilert F, et al. Phase II study of the mitochondrial antioxidant MitoQ for hepatitis C. J Hepatol 2008;48:S318.
36. Reily C, Mitchell T, Chacko BK, Benavides GA, Murphy MP, Darley-Usmar VM. Mitochondrially targeted compounds and their impact on cellularbioenergetics. Redox Biol 2013;1:86-93.
37. Jadidian A, Antonelli PJ, Ojano-Dirain CP. Evaluation of apoptosis in HEI-OC1 cells treated with gentamicin with and without the mitochondria-targeted antioxidant MitoQ. Presented at the 48th AnnualAmerican Neurotology Society SpringMeeting in conjunction with COSM spring meetings in Orlando, Florida, April 12-13, 2013.
38. Jankauskas SS, Plotnikov EY, Morosanova MA, et al. Mitochondriatargeted antioxidant SkQR1 ameliorates gentamicin-induced renal failure and hearing loss. Biochemistry (Mosc) 2012;77:666-70.
39. Chittenden T, Harrington EA, O'Connor R, et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995;374:733-6.
40. Inohara N, Ding L, Chen S, Nunez G. Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J 1997;16:1686-94.
41. Jiang H, Sha SH, Schacht J. NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res 2005;79:644-51.
42. Le Prell CG, Lang D, Joseph D, Kalantar N. Dietary nutrients attenuate cell death events in the inner ear after noise insult. Abs Assoc Res Otolaryngol 2011;34:218-9.
43. Ji LL. Antioxidant signaling in skeletal muscle: a brief review. Exp Gerontol 2007;42:582-93.
44. Miguel F, Augusto AC, Gurgueira SA. Effect of acute vs chronic H2O2-induced oxidative stress on antioxidant enzyme activities. Free Radic Res 2009;43:340-7.